Prescribing Medication Abortion via Telehealth: The ‘Rules of the Road’ in a Post-Dobbs World

In the aftermath of the Dobbs v. Jackson Supreme Court decision, there is ongoing discussion about the role that medication abortion—particularly tele-medication abortion (teleMAB)— will play in connecting women to abortion services. The legal landscape post-Dobbs is varied, complicated and rife with potential risks. Each state has its own laws governing telehealth and abortion services, including state laws that specifically prohibit or regulate teleMAB.

In a new webinar, Manatt will guide providers and advocates through the policy and regulatory complexities surrounding the clinical delivery of teleMAB services. Key topics that will be covered include:

  • A background on medication abortion, including who is eligible and how it can be delivered using telehealth
  • An overview of state laws on telehealth and abortion that can restrict or promote access to teleMAB services
  • Illustrative scenarios that show how different types of state laws can impact providers’ ability to deliver teleMAB services, including an assessment of associated risks
  • A discussion of still unanswered questions—and predictions about what to expect next

Even if you can’t make our live session on October 18, register free now, and you’ll receive a link to view the program on demand.

Speakers:

Date and Time:

Tuesday, October 18
3:00 – 4:00 p.m. ET

CLE:

This program has been approved for 1.0 NY CLE Skills (transitional and non-transitional) and for 1.0 CA MCLE General credit.


If you would like to receive an audio transcript of this webinar due to accessibility issues, please email us at webinars@manatt.com.

This program does not constitute legal advice, nor does it establish an attorney-client relationship. Views expressed by presenters are strictly their own and should not be construed to be the views of Manatt or attributed to Manatt.

manatt-black

ATTORNEY ADVERTISING

pursuant to New York DR 2-101(f)

© 2022 Manatt, Phelps & Phillips, LLP.

All rights reserved